Crop science giant Bayer says it has settled 17,000 glyphosate cases so far and hopes for a supreme court ruling next year.

Heading into the second half of their 2025 financial year, Bayer leaders echo positive comments surrounding the company’s ...

The additional financial provisions support Bayer’s stated goal to get glyphosate litigation and liabilities contained by ...

Bayer has recently settled thousands of cases over claims the active ingredient in its Roundup weedkiller causes cancer, ...

A French court ruled on Thursday that a complaint brought by a family against Bayer claiming their son's disabilities were ...

(Reuters) -German pharmaceutical and biotechnology group Bayer said on Thursday it had set aside an additional 1.2 billion ...

German pharmaceutical giant Bayer said Tuesday it had struck a deal valued at up to $1.3 billion (1.1 billion euros) with a US ...

Bayer’s Roundup pesticide is linked with cancer. Its fight to dodge accountability threatens to leave sick people holding the ...

Bayer investor Union Investment called on Wednesday for the German company to reconsider its litigation strategy for glyphosate and a key U.S. trial lawyer signaled interest in re-starting ...

Bayer seems to be pursuing a “both/and” strategy with regard to its signature glyphosate-based pesticide Roundup. It is defending against lawsuits and attacks on glyphosate, even while it ...

Bayer was last month ordered to pay $2.25 billion to a Pennsylvania man who said he developed cancer from exposure to glyphosate, though the amount of damages is expected to be reduced on appeal.

In an attempt to get out from under the cloud of current Roundup-related litigation, Bayer announced Thursday it would stop using glyphosate in lawn and garden formulations in the U.S. starting in ...